DE2926828A1 - METHOD FOR PRODUCING N, N'-DISUBSTITUTED 2-NAPHTHALINAETHANIMIDAMIDES AND THEIR SALTS AND 2-NPHTHYLIMIDOACETIC ACID ESTER SALTS - Google Patents
METHOD FOR PRODUCING N, N'-DISUBSTITUTED 2-NAPHTHALINAETHANIMIDAMIDES AND THEIR SALTS AND 2-NPHTHYLIMIDOACETIC ACID ESTER SALTSInfo
- Publication number
- DE2926828A1 DE2926828A1 DE19792926828 DE2926828A DE2926828A1 DE 2926828 A1 DE2926828 A1 DE 2926828A1 DE 19792926828 DE19792926828 DE 19792926828 DE 2926828 A DE2926828 A DE 2926828A DE 2926828 A1 DE2926828 A1 DE 2926828A1
- Authority
- DE
- Germany
- Prior art keywords
- general formula
- salts
- carbon atoms
- formula iii
- acid ester
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000002253 acid Substances 0.000 title claims description 16
- 238000004519 manufacturing process Methods 0.000 title description 3
- 229910052757 nitrogen Inorganic materials 0.000 title description 3
- -1 ester salts Chemical class 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 15
- 150000001875 compounds Chemical class 0.000 claims description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- 238000006243 chemical reaction Methods 0.000 claims description 12
- 150000003839 salts Chemical class 0.000 claims description 9
- 150000003973 alkyl amines Chemical class 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- 239000012458 free base Substances 0.000 claims description 4
- 125000005843 halogen group Chemical group 0.000 claims description 4
- LPCWDVLDJVZIHA-UHFFFAOYSA-N 2-naphthalen-2-ylacetonitrile Chemical compound C1=CC=CC2=CC(CC#N)=CC=C21 LPCWDVLDJVZIHA-UHFFFAOYSA-N 0.000 claims description 3
- LHYUMRWJTVKTPD-UHFFFAOYSA-N 2-naphthalen-2-ylethanimidamide Chemical class C1=CC=CC2=CC(CC(=N)N)=CC=C21 LHYUMRWJTVKTPD-UHFFFAOYSA-N 0.000 claims description 3
- 229910052801 chlorine Inorganic materials 0.000 claims description 3
- 239000012442 inert solvent Substances 0.000 claims description 3
- 125000004429 atom Chemical group 0.000 claims description 2
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 2
- 229910000039 hydrogen halide Inorganic materials 0.000 claims description 2
- 239000012433 hydrogen halide Substances 0.000 claims description 2
- 125000001624 naphthyl group Chemical group 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 12
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
- 239000011541 reaction mixture Substances 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 125000004494 ethyl ester group Chemical group 0.000 description 5
- 150000002825 nitriles Chemical class 0.000 description 5
- 239000013078 crystal Substances 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 3
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- FJSKXQVRKZTKSI-UHFFFAOYSA-N 2,3-dimethylfuran Chemical compound CC=1C=COC=1C FJSKXQVRKZTKSI-UHFFFAOYSA-N 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 238000006136 alcoholysis reaction Methods 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 229940005513 antidepressants Drugs 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- PZYUESQIXBTVPG-UHFFFAOYSA-N ethanimidamide;naphthalene Chemical class CC(N)=N.C1=CC=CC2=CC=CC=C21 PZYUESQIXBTVPG-UHFFFAOYSA-N 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910000042 hydrogen bromide Inorganic materials 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C1/00—Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C15/00—Cyclic hydrocarbons containing only six-membered aromatic rings as cyclic parts
- C07C15/20—Polycyclic condensed hydrocarbons
- C07C15/24—Polycyclic condensed hydrocarbons containing two rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C239/00—Compounds containing nitrogen-to-halogen bonds; Hydroxylamino compounds or ethers or esters thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C241/00—Preparation of compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
- C07C257/04—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines without replacement of the other oxygen atom of the carboxyl group, e.g. imino-ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
- C07C257/04—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines without replacement of the other oxygen atom of the carboxyl group, e.g. imino-ethers
- C07C257/06—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines without replacement of the other oxygen atom of the carboxyl group, e.g. imino-ethers having carbon atoms of imino-carboxyl groups bound to hydrogen atoms, to acyclic carbon atoms, or to carbon atoms of rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
- C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
- C07C257/14—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
Die Erfindung "betrifft den in den vorstehenden Patentansprüchen gekennzeichneten Gegenstand.The invention "relates to what is stated in the preceding claims featured item.
Die Reste R und R? können gleich oder verschieden sein. Die Alkyl- und Alkoxyreste können unverzweigt oder verzweigt sein. Als Halogenatome R und R£ kommen Fluor-, Chlor- oder Bromatome in Frage. 'The remainders R and R ? can be the same or different. The alkyl and alkoxy radicals can be unbranched or branched. Possible halogen atoms R and R £ are fluorine, chlorine or bromine atoms. '
Bevorzugt ist die Herstellung von Salzen der Verbindungen der allgemeinen Formel I mit pharmakologisch verträglichen Säuren.The preparation of salts of the compounds is preferred of the general formula I with pharmacologically acceptable acids.
In der US-PS 3 903 163 sind verschiedene Ν,ϊΓ-disubstituierte-2-Naphthalinathanimxdamxde und ihre Salze mit pharmakologisch verträglichen Säuren beschrieben, die ZNS-Aktivität aufweisen. Die Verbindungen eignen sich besonders als Antidepressiva und zur Bekämpfung von Angst zuständen. Die Verbindungen werden hergestellt durch Umsetzung von 2-Haphthylacetonitril mit primären Aminen und primären Ammoniumionen. Die Verbindüngen können auch durch Umsetzung der entsprechenden substituierten Naphthylacetamide mit einem Irialkyloxoniumfluoborat und weitere Umsetzung des erhaltenen N-alkylsubstituierten Arylnitriliumfluoborats , mit einem primären Alkylamin hergestellt werden. Keines dieser Verfahren ist zur großtechnischen Herstellung der Verbindungen befriedigend.In US Pat. No. 3,903,163 there are various Ν, ϊΓ-disubstituted-2-naphthalinathanimxdamxde and their salts with pharmacologically acceptable acids which have CNS activity. The compounds are particularly suitable as antidepressants and for combating anxiety. The connections are produced by reacting 2-haphthylacetonitrile with primary amines and primary ammonium ions. The connections can also be achieved by reacting the corresponding substituted naphthylacetamides with an Irialkyloxoniumfluoborat and further reacting the obtained N-alkyl-substituted Aryl nitrilium fluoroborate, with a primary alkyl amine. Neither of these procedures is for large-scale use Production of the connections satisfactory.
Der Erfindung liegt somit die Aufgabe zugrunde, ein neues Verfahren zur Herstellung von Ν,Ν'-disubstituierten 2-lfaphthalinäthanimidamiden und ihren Salzen zu schaffen, das technisch einfach durchführbar ist und in guten Ausbeuten verläuft. The invention is therefore based on the object of a new Process for the preparation of Ν, Ν'-disubstituted 2-lfaphthalinethanimidamides and to create their salts, which is technically easy to carry out and which proceeds in good yields.
Im erfindungsgemäßen Verfahren werden die Verbindungen der allgemeinen Formel I in einem zweistufigen Verfahren hergestellt. In der ersten Stufe wird das litril durch Alkoholyse mit einem wasserfreien Alkohol und einer wasserfreien SäureIn the process according to the invention, the compounds of general formula I produced in a two-step process. In the first stage the litrile becomes through alcoholysis with an anhydrous alcohol and an anhydrous acid
909883/0826 _i909883/0826 _i
in das entsprechende Imidoestersalz überführt. In der zweiten Stufe wird das erhaltene Imidoestersalz mit einem Überschuß eines wasserfreien Alkylamins zum K^lP-disubstituierten Naphthalinäthanimidamidsalz umgesetzt. Das erfindungsgemäße Verfahren kann durch folgendes Reaktionsschema wiedergegeben werden:converted into the corresponding imido ester salt. In the second stage, the imido ester salt obtained is used with an excess an anhydrous alkylamine to the K ^ lP-disubstituted naphthalene ethane imidamide salt implemented. The process according to the invention can be represented by the following reaction scheme will:
1. Stufe1st stage
CH CN.CH CN.
, <Vn , <Vn
+ R3OH + HXrr+ R 3 OH + HXrr
(H)(H)
.CH^COR3 .CH ^ COR 3
2. Stufe2nd stage
fill)+ 2RNH,fill) + 2RNH,
CH_CNHRCH_CNHR
2H .
NR-HX 2 H.
NR-HX
(IV)(IV)
R, R^, R£, m und ja haben die vorstehend angegebene Bedeutung.R, R ^, R £, m and ja have the meanings given above.
R, stellt einen Alkylrest mit im allgemeinen 1 bis 3 Kohlen-R represents an alkyl radical with generally 1 to 3 carbons
0
stoffatomen dar und X ist ein Halogenidion. 0
Substance atoms and X is a halide ion.
Das UTjN'-disubstituierte 2-Naphthalinäthanimidamidsalz der allgemeinen Formel IV kann nach herkömmlichen Methoden isoliert werden, beispielsweise durch Filti'ieren oder Zentrifu-The UTjN'-disubstituted 2-naphthalenethanimidamide salt of general formula IV can be isolated by conventional methods, for example by filtering or centrifuging
L 909883/0826L 909883/0826
ORIGINAL INSPECTEDORIGINAL INSPECTED
gieren. Die freie Base der allgemeinen Formel I kann durch Neutralisation des Salzes mit einer wäßrigen Base hergestellt werden. Beispielsweise kann das Salz mit einer äquimolaren Menge Natriumhydroxid in wäßriger Lösung oder überschüssiger wäßriger Natriumcarbonatlösung versetzt werden. Sodann wird die freie Base durch Extraktion mit einem organischen Lösungsmittel isoliert. . Das Salz und die freie Base können nach herkömmlichen Methoden noch weiter gereinigt werden, beispielsweise durch Waschen oder Umkristallisation.yaw. The free base of the general formula I can by Neutralization of the salt made with an aqueous base will. For example, the salt with an equimolar amount of sodium hydroxide in aqueous solution or in excess aqueous sodium carbonate solution are added. The free base is then extracted with an organic solvent isolated. . The salt and free base can be further purified by conventional methods, for example by washing or recrystallization.
Die Erfindung betrifft auch die neuen 2-Naphthylimidoessig- ' säureestersalze der allgemeinen Formel III, die wertvolle Zwischenprodukte im erfindungsgemäßen Verfahren darstellen. Besonders bevorzugt sind Verbindungen der allgemeinen Formel III, in der η und m den Wert 0 haben, sowie Verbindungen, in denen die Substituenten in der 1-, 3- oder 4-Stellung des Naphthalingerüstes stehen. Besonders bevorzugt sind Verbindungen der allgemeinen-Formel III, die in der 1-Stellung ein Chloratom tragen.The invention also relates to the new 2-Naphthylimidoessig- ' acid ester salts of the general formula III, which are valuable intermediates in the process according to the invention. Particularly preferred are compounds of the general formula III in which η and m have the value 0, as well as compounds in which the substituents in the 1-, 3- or 4-position des Stand naphthalene structure. Compounds of the general formula III which are in the 1-position are particularly preferred Carry chlorine atom.
In der Praxis wird das erfindungsgemäße Verfahren folgendermaßen durchgeführt:In practice, the method according to the invention is carried out as follows:
In der ersten Stufe wird ein 2-Naphthy!acetonitril der allgemeinen Formel II in einem inerten Lösungsmittel, wie Toluol, Chloroform oder einem Äther, gelöst und mit einem wasserfreien niederen aliphatischen Alkohol, wie Methanol, Äthanol·, oder Propanol, versetzt. Pro Mol Nitril werden etwa 1 bis 1,4 Mol Alkohol verwendet. Besonders bevorzugt ist ein Mengenverhältnis von 1 Mol Nitril zu 1,15 Mol des Alkohols. Eine was— serfreie, pharmakologisch verträgliche starke Säure, im allgemeinen ein Halogenwasserstoff, wie Chlorwasserstoff oder Bromwasserstoff, wird in solcher Geschwindigkeit zugegeben, daß die Reaktionstemperatur 400C nicht übersteigt. Die bevorzugte Reaktionstemperatur für die erste Stufe liegt im Bereich von 0 bis 30°C. Zur vollständigen Umsetzung ist mindestens 1 Äquivalent der Säure erforderlich. Größere MengenIn the first stage, a 2-naphthy! Acetonitrile of the general formula II is dissolved in an inert solvent such as toluene, chloroform or an ether, and an anhydrous lower aliphatic alcohol such as methanol, ethanol or propanol is added. About 1 to 1.4 moles of alcohol are used per mole of nitrile. A quantitative ratio of 1 mol of nitrile to 1.15 mol of the alcohol is particularly preferred. A water-free, pharmacologically acceptable strong acid, generally a hydrogen halide such as hydrogen chloride or hydrogen bromide is added in such a rate that the reaction temperature not exceeding 40 0 C. The preferred reaction temperature for the first stage is in the range from 0 to 30 ° C. At least 1 equivalent of the acid is required for complete conversion. Big amount of
L 909883/0826 JL 909883/0826 J.
können bis zum Sättigungspunkt zugesetzt werden, ohne die Umsetzung jedoch signifikant zu beeinträchtigen. Die Umsetzung wird solange durchgeführt, bis praktisch das gesamte Nitril in das Imidoestersalz überführt ist. Dies erfordert im allgemeinen etwa 15 Stunden. Der Ablauf der Umsetzung kann durch DünnschichtChromatographie verfolgt werden. Das Verschwinden des eingesetzten Nitrils zeigt die vollständige Umsetzung an. Das Imidoestersalz der allgemeinen Formel III kristallisiert gewöhnlich aus dem Reaktxonsgemisch aus und wird abfiltriert. Die Umsetzung soll nicht bei höheren Drükken als Atmosphärendruck durchgeführt werden, da andernfalls unerwünschte Hebenrcaktionen erfolgen, die die Reinheit des Produkts beeinträchtigen.can be added up to the saturation point, but without significantly affecting the conversion. The implementation is carried out until practically all of the nitrile has been converted into the imido ester salt. This requires generally about 15 hours. The course of the reaction can be followed by thin-layer chromatography. The disappearance of the nitrile used shows the complete conversion. The imido ester salt of the general formula III usually crystallizes out of the reaction mixture and is filtered off. The implementation should not take place at higher pressures than atmospheric pressure, otherwise unwanted lifting actions take place, which affect the purity of the Affect the product.
In der zweiten Stufe des erfindungsgemäßen Verfahrens wird das erhaltene Imidoestersalz der allgemeinen Formel III mit einem wasserfreien Alkylamin in einem inerten Lösungsmittel, wie Methanol, Äthanol oder Dimethylfuran, und gegebenenfalls unter Druck, umgesetzt. Die Reaktionstemperatur wird auf einen Wert im Bereich von etwa 4-5 bis etwa 1200G, vorzugsweise von 50 bis 8O0G eingestellt. Die Umsetzung wird solange durchgeführt, bis praktisch das gesamte Imidoestersalz in das Endprodukt überführt ist. Im allgemeinen wird das Alkylamin im Überschuß in einer Menge von mindestens 2 Äquivalenten pro eingesetztes Nitril der allgemeinen Formel II verwendet, um gute Ausbeuten zu erzielen.In the second stage of the process according to the invention, the imido ester salt of the general formula III obtained is reacted with an anhydrous alkylamine in an inert solvent such as methanol, ethanol or dimethylfuran, and optionally under pressure. The reaction temperature is preferably set to a value in the range of about 4-5 to about 120 0 G of from 50 to 8O 0 G. The reaction is carried out until practically all of the imido ester salt has been converted into the end product. In general, the alkylamine is used in excess in an amount of at least 2 equivalents per nitrile of the general formula II used, in order to achieve good yields.
Die Beispiele erläutern das erfindungsgemäße Verfahren.The examples explain the process according to the invention.
Herstellung von 2-Naphthylimidoessigsäureäthylester-hydrochlorid Production of ethyl 2-naphthylimidoacetate hydrochloride
Ein Reaktionsgefäß wird mit 40,0 g (0,239 Mol) 2-Naphthylacetonitril, 12,7 g (0,274 Mol) wasserfreiem Äthanol und 400 ml Toluol beschickt. Das erhaltene Gemisch wird auf 2°C abgekühlt und sodann wird wasserfreier Chlorwasserstoff ein-A reaction vessel is filled with 40.0 g (0.239 mol) of 2-naphthylacetonitrile, 12.7 g (0.274 mol) of anhydrous ethanol and 400 ml of toluene were charged. The resulting mixture is brought to 2 ° C cooled and then anhydrous hydrogen chloride is
L 909883/0826 -JL 909883/0826 -J
geleitet, bis die temperatur 10°C erreicht hat. Insgesamt werden 17,4 g (0,477 Mol) Chlorwasserstoff eingeleitet. Nach beendeter Zugabe wird das Reaktionsgemisch etwa 2 Stunden bei 2 bis 10°C unter Kühlung gerührt. Danach wird das Kühlbad entfernt und das Reaktionsgemisch auf Raumtemperatur erwärmen gelassen. Das Reaktionsgemisch wird weitere 15 bis 18 Stunden gerührt. Es bildet sich eine weiße dicke Kristallaufschlämmung. Überschüssiger Chlorwasserstoff wird durch Einleiten von Stickstoff in die Kristallmasse verdrängt. Die Kristalle werden abfiltriert, mit Toluol gewaschen und zunächst an der Luft und hierauf unter vermindertem Druck getrocknet. Es werden 57,7 g (97% d.Th.) der ^Dübelverbindung vom P. 202 bis 204-0C erhalten. Beim Erhitzen lagert sich das Imidoestersalz in das entsprechende 2-Haphthylacetamid um. Elementar analyse: CH Nuntil the temperature has reached 10 ° C. A total of 17.4 g (0.477 mol) of hydrogen chloride are passed in. After the addition has ended, the reaction mixture is stirred for about 2 hours at 2 to 10 ° C. with cooling. The cooling bath is then removed and the reaction mixture is allowed to warm to room temperature. The reaction mixture is stirred for a further 15 to 18 hours. A white thick crystal slurry forms. Excess hydrogen chloride is displaced into the crystal mass by introducing nitrogen. The crystals are filtered off, washed with toluene and dried first in air and then under reduced pressure. There are obtained 57.7 g (97% of theory) of the compound from P. ^ dowel 202 to 204- 0 C. When heated, the imido ester salt rearranges into the corresponding 2-haphthylacetamide. Elemental analysis: CH N
gef.: 67,3 6,70 5,62 ber.: 67,3 6,46 5,61found: 67.3 6.70 5.62 calc .: 67.3 6.46 5.61
B e i s ρ i e 1 2 Herstellung von N,Iil-Dimeth7l-2-naphthalinäthanimiaamidhydrochlorid B ice ρ 1 IE 2 Preparation of N, Ii l -Dimeth7l-2-naphthalinäthanimiaamidhydrochlorid
In einem 100 ml fassenden Reaktionsgefäß, das mit einem Rührwerk, Thermometer, Tropftrichter mit Druckausgleich und Rückflußkühler mit Trockenrohr ausgerüstet ist, werden 11,95 g (0,048 Mol) 2^Naphthylimidoessigsäureäthylester-hydroehlorid vorgelegt. Sodann wird eine Lösung von 21,2 g (0,683 Mol)In a 100 ml reaction vessel, which is equipped with a stirrer, Thermometer, dropping funnel with pressure compensation and The reflux condenser is equipped with a drying tube, 11.95 g (0.048 mol) of 2 ^ naphthylimidoacetic acid ethyl ester hydrochloride submitted. Then a solution of 21.2 g (0.683 mol)
35 nil ..35 nil ..
Methylamin ±ψwasserfreiem Äthanol rasch zugegeben. Die Temperatur des Reaktionsgemisches steigt auf 65°C an und fällt auf etwa 30°C ab, sobald die gesamte Lösung zugesetzt worden ist. Hierauf wird das Reaktionsgemisch 21 Stunden auf 50 bis 53°C erhitzt. Danach wird das Reaktionsgemisch auf 2°C abgekühlt, und die weißen Kristalle werden abfiltriert. Das Produkt wird mit Toluol gewaschen und getrocknet. Es werden 10,2 g (85% d.Th.) der Titelverbindung erhalten. Das Rohprodukt wird aus wasserfreiem Äthanol umkristallisiert. Es werden 8,97 S der Titelverbindung vom F. 225 bis 227°C erhalten. Methylamine ± ψ anhydrous ethanol added quickly. The temperature of the reaction mixture rises to 65 ° C and drops to about 30 ° C once all of the solution has been added. The reaction mixture is then heated to 50 to 53 ° C. for 21 hours. The reaction mixture is then cooled to 2 ° C. and the white crystals are filtered off. The product is washed with toluene and dried. 10.2 g (85% of theory) of the title compound are obtained. The crude product is recrystallized from anhydrous ethanol. There are obtained 8.97 S of the title compound, melting at 225-227 ° C.
L 809883/0828 _iL 809883/0828 _i
Gemäß Beispiel 1 werden noch weitere neue 2-Naphthylimidoessigsäureestersalze der allgemeinen Formel III hergestellt. Diese Verbindungen eignen sich zur Herstellung der entsprechenden Ν,Ν'-disubstituierten 2-Naphthalinäthanimidamide.According to Example 1, further new 2-naphthylimidoacetic acid ester salts are made of the general formula III produced. These compounds are suitable for the preparation of the corresponding Ν, Ν'-disubstituted 2-naphthalenethanimidamides.
Es werden folgende Zwischenprodukte hergestellt:The following intermediate products are produced:
l-Chlor-2-naphthylimidoessigsäureäthylester-hydrochlorid; 6-Methoxy-2-naphthylimidoessigsäureäthylester-hydrochlorid; 6-Methyi-2-naphthylimidoessigsäureäthylester-hydrochlorid; 3-Methyl-2-naphthylimidoessigsäureäthylester-hydrochlorid; l-Hydroxy-2-naphthylimidoessigsäureäthylester-hydrochloridj o-Hydroxy-^-naphthylimidoessigsäureäthylester-hydrochlorid.ethyl l-chloro-2-naphthylimidoacetate hydrochloride; 6-methoxy-2-naphthylimidoacetic acid ethyl ester hydrochloride; 6-methyl-2-naphthylimidoacetic acid ethyl ester hydrochloride; 3-methyl-2-naphthylimidoacetic acid ethyl ester hydrochloride; Ethyl l-hydroxy-2-naphthylimidoacetate hydrochloride j o-Hydroxy - ^ - naphthylimidoacetic acid ethyl ester hydrochloride.
Andere Zwischenprodukte der allgemeinen Formel III können in ähnlicher Weise hergestellt werden.Other intermediates of general formula III can be prepared in a similar manner.
809883/0826809883/0826
Claims (9)
Midland, Mick., V.St.A.THE DOV CHEMICAL COMPANY
Midland, Mick., V.St.A.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US92169078A | 1978-07-03 | 1978-07-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
DE2926828A1 true DE2926828A1 (en) | 1980-01-17 |
Family
ID=25445831
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE19792926828 Ceased DE2926828A1 (en) | 1978-07-03 | 1979-07-03 | METHOD FOR PRODUCING N, N'-DISUBSTITUTED 2-NAPHTHALINAETHANIMIDAMIDES AND THEIR SALTS AND 2-NPHTHYLIMIDOACETIC ACID ESTER SALTS |
Country Status (12)
Country | Link |
---|---|
JP (1) | JPS559095A (en) |
AR (1) | AR230619A1 (en) |
BE (1) | BE877449A (en) |
CA (1) | CA1130305A (en) |
CH (1) | CH641764A5 (en) |
DE (1) | DE2926828A1 (en) |
DK (1) | DK273079A (en) |
ES (1) | ES482113A1 (en) |
FR (1) | FR2430414A1 (en) |
GB (1) | GB2024223B (en) |
IT (1) | IT1121792B (en) |
NL (1) | NL7904774A (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4495108A (en) * | 1983-03-11 | 1985-01-22 | E. I. Du Pont De Nemours And Company | Process for preparing dialkyl propanediimidate dihydrohalides |
US5180379A (en) * | 1991-04-04 | 1993-01-19 | Minnesota Mining And Manufacturing Company | Electrode with pre-wired leads |
JPH08293371A (en) * | 1995-04-20 | 1996-11-05 | Nippon Denki Factory Eng Kk | Ic socket |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1468926A1 (en) * | 1964-07-31 | 1969-02-20 | Rhone Poulenc Sa | Process for the preparation of new acetamidine derivatives |
DE1951258A1 (en) * | 1968-10-17 | 1970-11-05 | Lilly Co Eli | Beta-naphthylacetamidine and its salts |
US3742000A (en) * | 1969-06-03 | 1973-06-26 | Grace W R & Co | Imidoether and amidine derivatives of substituted fatty amides |
DE1817861B2 (en) * | 1967-11-29 | 1973-09-06 | Orsymonde, Paris | N-ALKYLATED 3,4-METHYLENOXYMANDEL ACID AMIDINES AND THEIR PHARMACOLOGICALLY NON-TOXIC ACID ADDITIONAL SALTS AND PHARMACEUTICAL AGENTS CONTAINING THESE |
DD109864A1 (en) * | 1973-11-20 | 1974-11-20 | ||
DE2449840A1 (en) * | 1973-10-19 | 1975-04-24 | Kao Corp | ADAMANTYLAMIDINE AND THE PROCESS FOR THEIR MANUFACTURE |
DE2019307B2 (en) * | 1969-04-24 | 1979-09-27 | Orsymonde S.A., Paris | Mandelamidine derivatives and medicinal products containing them |
DE2542791C2 (en) * | 1974-10-02 | 1984-11-08 | The Dow Chemical Co., Midland, Mich. | N, N'-Disubstituted Naphthylacetamidines |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5198201A (en) * | 1975-02-18 | 1976-08-30 | n22 chikan omega amijino arufua aminosanjudotaimataha sonosanfukaenno seizoho |
-
1979
- 1979-06-13 IT IT23509/79A patent/IT1121792B/en active
- 1979-06-19 NL NL7904774A patent/NL7904774A/en not_active Application Discontinuation
- 1979-06-28 DK DK273079A patent/DK273079A/en not_active Application Discontinuation
- 1979-06-29 FR FR7917017A patent/FR2430414A1/en active Granted
- 1979-06-29 CA CA330,828A patent/CA1130305A/en not_active Expired
- 1979-07-02 GB GB7922870A patent/GB2024223B/en not_active Expired
- 1979-07-02 ES ES482113A patent/ES482113A1/en not_active Expired
- 1979-07-02 CH CH616579A patent/CH641764A5/en not_active IP Right Cessation
- 1979-07-03 AR AR277173A patent/AR230619A1/en active
- 1979-07-03 JP JP8437179A patent/JPS559095A/en active Granted
- 1979-07-03 BE BE0/196104A patent/BE877449A/en not_active IP Right Cessation
- 1979-07-03 DE DE19792926828 patent/DE2926828A1/en not_active Ceased
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1468926A1 (en) * | 1964-07-31 | 1969-02-20 | Rhone Poulenc Sa | Process for the preparation of new acetamidine derivatives |
DE1817861B2 (en) * | 1967-11-29 | 1973-09-06 | Orsymonde, Paris | N-ALKYLATED 3,4-METHYLENOXYMANDEL ACID AMIDINES AND THEIR PHARMACOLOGICALLY NON-TOXIC ACID ADDITIONAL SALTS AND PHARMACEUTICAL AGENTS CONTAINING THESE |
DE1951258A1 (en) * | 1968-10-17 | 1970-11-05 | Lilly Co Eli | Beta-naphthylacetamidine and its salts |
DE2019307B2 (en) * | 1969-04-24 | 1979-09-27 | Orsymonde S.A., Paris | Mandelamidine derivatives and medicinal products containing them |
US3742000A (en) * | 1969-06-03 | 1973-06-26 | Grace W R & Co | Imidoether and amidine derivatives of substituted fatty amides |
DE2449840A1 (en) * | 1973-10-19 | 1975-04-24 | Kao Corp | ADAMANTYLAMIDINE AND THE PROCESS FOR THEIR MANUFACTURE |
DD109864A1 (en) * | 1973-11-20 | 1974-11-20 | ||
DE2542791C2 (en) * | 1974-10-02 | 1984-11-08 | The Dow Chemical Co., Midland, Mich. | N, N'-Disubstituted Naphthylacetamidines |
Non-Patent Citations (4)
Title |
---|
J.Pharm.Sci. 62 (1973), S.1899-1900 * |
Pharmazie 28 (1973), S.427-431 * |
Pharmazie 28 (1973), S.724-729 * |
Pharmazie 29 (1974), S.263-267 * |
Also Published As
Publication number | Publication date |
---|---|
ES482113A1 (en) | 1980-04-01 |
IT1121792B (en) | 1986-04-23 |
JPS6343382B2 (en) | 1988-08-30 |
CH641764A5 (en) | 1984-03-15 |
DK273079A (en) | 1980-01-04 |
AR230619A1 (en) | 1984-05-31 |
GB2024223A (en) | 1980-01-09 |
BE877449A (en) | 1980-01-03 |
JPS559095A (en) | 1980-01-22 |
GB2024223B (en) | 1982-07-14 |
NL7904774A (en) | 1980-01-07 |
IT7923509A0 (en) | 1979-06-13 |
CA1130305A (en) | 1982-08-24 |
FR2430414A1 (en) | 1980-02-01 |
FR2430414B1 (en) | 1984-06-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69619809T2 (en) | METHOD FOR PRODUCING (S) -3- (AMINOETHYL) -5-METYLHEXANIC ACID | |
DE869956C (en) | Process for the preparation of organodisiloxanes | |
DE1720019C3 (en) | 1 -Benzyl-2-aminoacetyl-pyrrole derivatives, their salts and process for their preparation | |
CH640224A5 (en) | 2-pyrrolidone derivatives, PROCESS FOR PREPARING THEM AND THEIR USE FOR PRODUCING 4-AMINOHEX-5-enoic acid. | |
DE874311C (en) | Process for the production of organosilanes | |
DE3531067C2 (en) | ||
DE2926828A1 (en) | METHOD FOR PRODUCING N, N'-DISUBSTITUTED 2-NAPHTHALINAETHANIMIDAMIDES AND THEIR SALTS AND 2-NPHTHYLIMIDOACETIC ACID ESTER SALTS | |
DE3871591T2 (en) | METHOD FOR PRODUCING 1-PROPARGYL-2,4-DIOXOIMIDAZOLIDINE. | |
DE2602846C2 (en) | Process for the preparation of 2- (2-thienyl) ethylamines | |
DE2652004C3 (en) | l-Acyl-2-arylamino-2-imidazolines, process for their preparation and their use | |
DE2737481A1 (en) | PROCESS FOR THE PREPARATION OF 2-ALKYL- OR 2-CYCLOALKYL-4-METHYL-6-HYDROXYPYRIMIDINES | |
DE2609573A1 (en) | PROCESS FOR THE PRODUCTION OF 1- (1-PHENYLAETHYL) -1H-IMIDAZOL-5-CARBONIC ACID ESTERS, ITS ENANTIOMERS AND SALT WITH ACIDS | |
DE2409675A1 (en) | ALPHA-ALKYL (OR -ARYL) -THIO-5-HYDROXYTRYPTOPHANE DERIVATIVE AND PROCESS FOR ITS PRODUCTION | |
DE1918253A1 (en) | 3-hydroxyisoxazoles (soil fungicides) prodn | |
EP0010165B1 (en) | Process for the preparation of 6-hydroxypyrid-2-ones | |
DE1046046B (en) | Process for the preparation of quaternary phosphonium halides | |
DE1543288A1 (en) | Process for the preparation of dibenzocycloheptenylamines | |
DE2065698A1 (en) | PROCESS FOR THE PREPARATION OF 2ISOPROPYL-6-METHYL-4 (3H) -PYRIMIDONE | |
AT234691B (en) | Process for the preparation of new piperidine derivatives | |
DE2338409A1 (en) | 2-Aminobenzylamine derivs prepn. - by direct amination of 2-aminobenzyl derivs, used as secretolytics and anti-tussives | |
AT401931B (en) | Process for the preparation of (s,s)-n-(1-ethoxycarbonyl- 3-oxo-3-phenylpropyl)alanine phenylmethyl ester | |
DE2329251C2 (en) | Process for the preparation of disubstituted malononitrile | |
AT202125B (en) | Process for the preparation of new α-mercapto acid amides | |
AT366059B (en) | METHOD FOR PRODUCING NEW PHOSPHONIUM IMIDAZOLE COMPOUNDS AND THEIR ACID ADDITION SALTS | |
DE2802387C2 (en) | Process for the preparation of thiazo-üdin-4-one-acetic acid derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
OI | Miscellaneous see part 1 | ||
8110 | Request for examination paragraph 44 | ||
8131 | Rejection |